Literature DB >> 10391153

Calcium regulation in the human myocardium affected by dilated cardiomyopathy: a structural basis for impaired Ca2+-sensitivity.

S S Margossian1, P A Anderson, P D Chantler, M Deziel, P K Umeda, H Patel, W F Stafford, P Norton, A Malhotra, F Yang, J B Caulfield, H S Slayter.   

Abstract

Calcium regulation in the human heart is impaired during idiopathic dilated cardiomyopathy (IDC). Here, we analyze the structural basis for impairment in the regulatory mechanism. Regulation of contractility was monitored by MgATPase and Ca2+-binding assays as a function of calcium. Myofibrillar proteolysis and expression of troponin T isoforms were established by gel electrophoresis and by Western blots. Myofibrillar ATPase assays in low salt however, revealed a drastic lowering of calcium sensitivity in IDC myofibrils as indicated by reductions in both activation by high calcium and in EGTA-mediated inhibition of MgATPase. Structural changes in myofilament proteins were found in most IDC hearts, specifically proteolysis of myosin light chain 2 (LC2), troponin T and I (TnT and TnI), and sometimes a large isoform shift in TnT. IDC did not induce mutations in LC2 and troponin C (TnC), as established by cDNA sequence data from IDC cases, thus, calcium binding to IDC myofibrils was unaffected. Reassociation of IDC myofibrils with native LC2 raised MgATPase activation at high Ca2+ to control levels, while repletion with intact, canine TnI/TnT restored inhibition at low Ca2+. A model, identifying possible steps in the steric blocking mechanism of regulation, is proposed to explain IDC-induced changes in Ca2+-regulation. Moreover, shifts in TnT isoforms may imply either a genetic or a compensatory factor in the development and pathogenesis of some forms of IDC.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10391153     DOI: 10.1023/a:1006980405359

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  54 in total

1.  Alignment of schlieren and Rayleigh optical systems in the ultracentrifuge. II. A general procedure.

Authors:  E G Richards; D C Teller; V D Hoagland; R H Haschemeyer; H K Schachman
Journal:  Anal Biochem       Date:  1971-05       Impact factor: 3.365

2.  A direct regulatory role for troponin T and a dual role for troponin C in the Ca2+ regulation of muscle contraction.

Authors:  J D Potter; Z Sheng; B S Pan; J Zhao
Journal:  J Biol Chem       Date:  1995-02-10       Impact factor: 5.157

3.  Dynamics of the muscle thin filament regulatory switch: the size of the cooperative unit.

Authors:  M A Geeves; S S Lehrer
Journal:  Biophys J       Date:  1994-07       Impact factor: 4.033

4.  Preparation of myosin and its subfragments from rabbit skeletal muscle.

Authors:  S S Margossian; S Lowey
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

5.  Regulatory light-chains and scallop myosin. Full dissociation, reversibility and co-operative effects.

Authors:  P D Chantler; A G Szent-Györgyi
Journal:  J Mol Biol       Date:  1980-04-15       Impact factor: 5.469

6.  Troponin T isoform expression in humans. A comparison among normal and failing adult heart, fetal heart, and adult and fetal skeletal muscle.

Authors:  P A Anderson; N N Malouf; A E Oakeley; E D Pagani; P D Allen
Journal:  Circ Res       Date:  1991-11       Impact factor: 17.367

7.  Human cardiac troponin T: cloning and expression of new isoforms in the normal and failing heart.

Authors:  L Mesnard; D Logeart; S Taviaux; S Diriong; J J Mercadier; F Samson
Journal:  Circ Res       Date:  1995-04       Impact factor: 17.367

8.  Calcium-induced dimerization of troponin-C.

Authors:  S S Margossian; W F Stafford
Journal:  J Biol Chem       Date:  1982-02-10       Impact factor: 5.157

9.  Structural and enzymatic comparison of human cardiac muscle myosins isolated from infants, adults, and patients with hypertrophic cardiomyopathy.

Authors:  J J Schier; R S Adelstein
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

10.  Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy.

Authors:  G Cuda; L Fananapazir; W S Zhu; J R Sellers; N D Epstein
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

View more
  4 in total

1.  The gene expression fingerprint of human heart failure.

Authors:  Fen-Lai Tan; Christine S Moravec; Jianbo Li; Carolyn Apperson-Hansen; Patrick M McCarthy; James B Young; Meredith Bond
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

Review 2.  Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies.

Authors:  Jarmila Machackova; Judit Barta; Naranjan S Dhalla
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

3.  A dilated cardiomyopathy troponin C mutation lowers contractile force by reducing strong myosin-actin binding.

Authors:  David Dweck; Daniel P Reynaldo; Jose R Pinto; James D Potter
Journal:  J Biol Chem       Date:  2010-04-06       Impact factor: 5.157

4.  Partial and delayed release of troponin-I compared with the release of lactate dehydrogenase from necrotic cardiomyocytes.

Authors:  Lijuan Li; Marleen Hessel; Lizet van der Valk; Minka Bax; Irma van der Linden; Arnoud van der Laarse
Journal:  Pflugers Arch       Date:  2004-02-06       Impact factor: 3.657

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.